Showing results (181-190 of 209) with videos related to
Sort By:
Pageof 21
International Journal of Hematology|May 21, 2025
Whole-genome sequencing reveals genetic backgrounds in Japanese patients with hemophagocytic lymphohistiocytosis treated with the HLH-2004 protocolRyu Yanagisawa, Manabu Wakamatsu, Dan Tomomasa, et al.Transfusion|December 21, 2012
Replaced platelet concentrates containing a new additive solution, M-sol: safety and efficacy for pediatric patientsRyu Yanagisawa, Shigetaka Shimodaira, Shunsuke Kojima, et al.Pediatric Blood & Cancer|October 2, 2018
Comparison of conditioning regimens for autologous stem cell transplantation in children with acute myeloid leukemia: A nationwide retrospective study in JapanHirotoshi Sakaguchi, Hideki Muramatsu, Daiichiro Hasegawa, et al.Journal of Clinical Immunology|November 6, 2016
Hematopoietic Stem Cell Transplantation for XIAP Deficiency in JapanShintaro Ono, Tsubasa Okano, Akihiro Hoshino, et al.The Kurume Medical Journal|August 23, 2021
Single-Arm Non-Blinded Multicenter Clinical Trial on T-Cell-Replete Haploidentical Stem Cell Transplantation Using Low-Dose Antithymocyte Globulin for Relapsed and Refractory Pediatric Acute LeukemiaAkiko Kada, Atsushi Kikuta, Akiko M Saito, et al.Nature Communications|February 25, 2025
Synthetic short mRNA prevents metastasis via innate-adaptive immunityHikaru Hayashi, Sayaka Seki, Takeshi Tomita, et al.Frontiers in Oncology|August 22, 2025
Trial in progress: phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors expressing EPHB4 receptor (CARTiEr)Chikako Funasaka, Yoichi Naito, Hitomi Kubota, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 10, 2021
Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphomaSakiko Harada, Miki Ando, Jun Ando, et al.Bone Marrow Transplantation|February 6, 2019
Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemiaYasuhiro Okamoto, Kazuko Kudo, Ken Tabuchi, et al.Cytotherapy|December 9, 2014
Safety and tolerability of allogeneic dendritic cell vaccination with induction of Wilms tumor 1-specific T cells in a pediatric donor and pediatric patient with relapsed leukemia: a case report and review of the literatureShoji Saito, Ryu Yanagisawa, Kentaro Yoshikawa, et al.Pageof 21